1. Orlova A.I. Patentnye strategii v farmatsevtike: «patentnoe ozelenenie». «Zhurnal Suda po intellektual'nym pravam». 26.12.2019, s. 83-89; Medicare Prescription Drug, Improvement, and Modernization Act of 2003. United States Congress. Available at: https://www.congress.gov/108/plaws/publ173/PLAW-108publ173.pdf (accessed: 13.09.2023).
2. Schpero W., Wiener T., Carter S., Chatterjee P. Lobbying Expenditures in the US Health Care Sector, 2000-2020. JAMA Health Forum, 28.10.2022. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617167/#:~:text=Lobbying%expenditures%grew%by%more,vs%$358.2%million%in%2000. (accessed: 08.10.2023).
3. FACT SHEET: Biden-Harris Administration Announces First Ten Drugs Selected for Medicare Price Negotiation, 29.08.2023. Available at: https://www.whitehouse.gov/briefing-room/statements-releases/2023/08/29/fact-sheet-biden-harris-administration-announces-first-ten-drugs-selected-for-medicare-price-negotiation/ (accessed: 08.10.2023).
4. Trump Administration Announces Framework and Leadership for 'Operation Warp Speed’. The Department of Defense, 15.05.2020. Available at: https://www.defense.gov/News/Releases/Release/Article/2310750/trump-administration-announces-framework-and-leadership-for-operation-warp-speed/ (accessed: 10.09.2023).
5. After nearly $1B in research funding, Moderna takes $1.5B coronavirus vaccine order from U.S. 12.08.2020. Available at: https://www.fiercepharma.com/pharma/after-nearly-1b-research-funding-moderna-takes-1-5b-coronavirus-vaccine-order-from-u-s (accessed: 08.10.2023); Pfizer, BioNTech snare $1.95B deal with U.S. government for 100M-plus doses of COVID-19 vaccine, 22.07.2020. Available at: https://www.fiercepharma.com/manufacturing/pfizer-biontech-snare-1-95b-deal-u-s-government-for-100m-plus-doses-covid-19-vaccine (accessed: 04.10.2023).
6. COVID-19 Vaccinations in the United States, 11.05.2023. Available at: https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-people-booster-percent-pop5 (accessed: 11.10.2023).
7. Hussain S Lalani, US public investment in development of mRNA covid-19 vaccines: retrospective cohort study, 01.03.2023. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975718/ (accessed: 09.09.2023).
8. Pfizer Inc to Review RSV Data Presented at ID Week Call, 20.10.2022. Available at: https://s28.q4cdn.com/781576035/files/doc_downloads/2022/10/IDWeek22/PFE-USQ_Transcript_2022-10-20.pdf (accessed: 01.10.2023).
9. Moderna Considers Price of $110-$130 for Covid-19 Vaccine 09.01.2023. Available at: https://www.wsj.com/articles/moderna-considers-price-of-110-130-for-covid-19-vaccine-11673289609 (accessed:18.09.2023).
10. ADULT POPULATION BY AGE GROUP UNITED STATES. Available at: https://datacenter.aecf.org/data/tables/6538-adult-population-by-age-group#detailed/1/any/false1095,2048,574,1729,37,871,870,573,869,36/117,2801,2802,2803/13515,13516 (accessed: 09.10.2023).
11. How to Make Enough Vaccine for the World in One Year, 26.05.2021. Available at: https://www.citizen.org/article/how-to-make-enough-vaccine-for-the-world-in-one-year/ (accessed: 27.08.2023)
12. VACCINE MONOPOLIES MAKE COST OF VACCINATING THE WORLD AGAINST COVID AT LEAST 5 TIMES MORE EXPENSIVE THAN IT COULD BE, 29.07.2021. Available at: https://www.oxfam.org.uk/media/press-releases/vaccine-monopolies-make-cost-of-vaccinating-the-world-against-covid-at-least-5-times-more-expensive-than-it-could-be/ (accessed: 10.09.2023).
13. Democratic Republic of Congo Healthcare Spending 2000-2023. Available at: https://www.macrotrends.net/countries/COD/democratic-republic-of-congo/healthcare-spending (accessed: 19.08.2023).
14. VACCINE MONOPOLIES MAKE COST OF VACCINATING THE WORLD AGAINST COVID AT LEAST 5 TIMES MORE EXPENSIVE THAN IT COULD BE, 29.07.2021. Available at: https://www.oxfam.org.uk/media/press-releases/vaccine-monopolies-make-cost-of-vaccinating-the-world-against-covid-at-least-5-times-more-expensive-than-it-could-be/ (accessed: 10.09.2023).
15. WHO SAGE Roadmap for Prioritizing Uses of COVID-19 Vaccines: An approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, 21.01.22. Available at: https://reliefweb.int/report/world/who-sage-roadmap-prioritizing-uses-covid-19-vaccines-approach-optimize-global-impact (accessed: 22.08.2023).
16. Coronavirus Pandemic (COVID-19). Available at: https://ourworldindata.org/coronavirus (accessed: 08.10.2023).
17. Head of UN health agency seeks vaccine booster moratorium, 05.08.2021. Available at: https://apnews.com/article/health-coronavirus-pandemic-united-nations-0e7636c1bcf61e70d9e61ce70300aa78 (accessed: 20.08.2023).
18. A Double Dose of Inequality: Pharma companies and the Covid-19 vaccines crisis, 22.09.2021. Available at: https://www.amnesty.org/en/documents/pol40/4621/2021/en/ (accessed: 11.10.2023).
19. Pharmaceutical companies reaping immoral profits from Covid vaccines yet paying low tax rates, 15.09.2021. Available at: https://actionaid.org/news/2021/pharmaceutical-companies-reaping-immoral-profits-covid-vaccines-yet-paying-low-tax-rates (accessed: 20.09.2023).
20. Pfizer FORM 10-K, 23.02.2023. Available at: https://www.sec.gov/Archives/edgar/data/78003/000007800323000024/pfe-20221231.htm (accessed: 08.10.2023).
Comments
No posts found